Anemia in reproductive-aged women


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Anemia is the most common health care problem, among women in particular. Lower hemoglobin count may be caused by a lot of factors, among which deficiency of trace elements has been recognized as essential for normal erythropoiesis. Irrespective of age, the main causes of anemia are deficiency of iron and folic acid, less frequently vitamin B 12. The etiology of each deficiency state may vary in different periods of a woman’s life, but the importance of clinical sequels of anemia is a maximum for reproductive-aged women, i.e. the negative effects of a deficiency affect not only their organism, but also pregnancy outcomes and neonatal health. Therapy regimens using iron, folic acid, B 12 or their combinations have been elaborated and practically introduced to prevent and correct deficiency states in reproductive-aged women.

全文:

受限制的访问

作者简介

M. Vinogradova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: mary-grape@ya.ru
MD, senior research associate in transfusion department

T. Fedorova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: t_fyodorova@oparina4.ru
MD, PhD, Chief of transfusion department

E. Strelnikova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_strelnikova@oparina4.ru
PhD, transfusiologist of transfusion department

E. Bakuridze

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_bakuridze@oparina4.ru
PhD, obstetrician-gynecologist of transfusion department

O. Rogachevsky

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: o_rogachevskiy@oparina4.ru
MD, PhD, the leading scientific researcher in transfusion department

参考

  1. Looker A.C., Dallman P.R., Carroll M.D., Gunter E.W., Johnson C.L. Prevalence of iron deficiency in the United States. JAMA. 1997; 277(12): 973-6.
  2. Schumann K., Elsenhans B., Maurer A. Iron supplementation. J. Trace Elem. Med. Biol. 1998; 12(3): 129-40.
  3. Viteri F.E. A new concept in the control of iron deficiency: community-based preventive supplementation of at-risk groups by the weekly intake of iron supplements. Biomed. Environ. Sci. 1998; 11(1): 46-60.
  4. Pavord S., Hunt B., eds. The obstetric hematology manual. Cambridge University Press; 2010. 276 p.
  5. Bergmann R.L., Gravens-Müller L., Hertwig K., Hinkel J., Andres B., Bergmann K.E., Dudenhausen J.W. Iron deficiency is prevalent in a sample of pregnant women at delivery in Germany. Eur. J. Obstet. Gynecol. Reprod. Biol. 2002; 102(2): 155-60.
  6. Allen L.H. Anemia and iron deficiency: effects on pregnancy outcome. Am. J. Clin. Nutr. 2000; 71(5, Suppl.): 1280S-4S.
  7. Sifakis S., Pharmakides G. Anemia in pregnancy. Ann. N. Y. Acad. Sci. 2000; 900: 125-36.
  8. Bothwell T.H., Charlton R.W., Cook J.D., Finch C.A. Iron metabolism in man. Oxford, UK: Blackwell Scientific Publications; 1979.
  9. Baker W.F.Jr., Lee R. Iron deficiency, folate, and vitamin B12 deficiency in pregnancy, obstetrics, and gynecology. In: Bick R.L., ed. Hematological complications in obstetrics, pregnancy, and gynecology. Cambridge University Press; 2009.
  10. Scholl T.O., Hediger M.L., Fischer R.L., Shearer J.W. Anemia vs. iron deficiency: increased risk of preterm delivery in a prospective study. Am. J. Clin. Nutr. 1992; 55(5): 985-8.
  11. Kadyrov M., Kosanke G., Kingdom J., Kaufmann P. Increased fetoplacental angiogenesis during first trimester in anaemic women. Lancet. 1998; 352(9142): 1747-9.
  12. Svanberg B., Arvidsson B., Norrby A., Rybo G., Sölvell L. Absorption of supplemental iron during pregnancy - a longitudinal study with repeated bone-marrow studies and absorption measurements. Acta Obstet. Gynecol. Scand. 1975; 48(Suppl.): 87-108.
  13. Van den Broek N.R., Letsky E.A., White S.A., Shenkin A. Iron status in pregnant women: which measurements are valid? Br. J. Haematol. 1998; 103(3): 817- 24.
  14. Lipschitz D.A., Cook J.D., Finch C.A. A clinical evaluation of serum ferritin as an index of iron stores. N. Engl. J. Med. 1974; 290(22): 1213-6.
  15. Breymann C. Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. Blood Cells Mol. Dis. 2002; 29(3): 506-16.
  16. Akesson A., Bjellerup P., Berglund M., Bremme K., Vahter M. Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am. J. Clin. Nutr. 1998; 68(6): 1241-6.
  17. Milman N., Clausen J., Byg K.E. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann. Hematol. 1998; 77(1-2): 13-9.
  18. Food and Nutrition Board, Institute of Medicine. Folate. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, D.C.: National Academy Press; 1998: 196-305.
  19. Haider B.A., Olofin I., Wang M., Spiegelman D., Ezzati M., Fawzi W.W.; Nutrition Impact Model Study Group (anaemia). Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. Br. Med. J. 2013; 346: f3443.
  20. Makrides M., Crowther C.A., Gibson R.A., Gibson R.S., Skeaff C.M. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am. J. Clin. Nutr. 2003; 78(1): 145-53.
  21. Juarez-Vazquez J., Bonizzoni E., Scotti A. Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trial. Br. J. Obstet. Gynaecol. 2002; 109(9): 1009-14.
  22. Bashiri A., Burstein E., Sheiner E., Mazor M. Anemia during pregnancy and treatment with intravenous iron: review of the literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003; 110(1): 2-7.
  23. Froessler B., Collingwood J., Hodyl N.A., Dekker G. Intravenous ferric carboxy-maltose for anaemia in pregnancy. BMC Pregnancy Childbirth. 2014; 14:115.
  24. Sifakis S., Angelakis E., Vardaki E., Koumantaki Y., Matalliotakis I., Koumantakis E. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecol. Obstet. Invest. 2001; 51(3): 150-6.
  25. Hershko C., Camaschella C. How I treat unexplained refractory iron deficiency anemia. Blood. 2014; 123(3): 326-33.
  26. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 2000; 71(1-2): 121-38.
  27. Mudd S.H., Skovby F., Levy H.L., Pettigrew K.D., Wilcken B., Pyeritz R.E. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am. J. Hum. Genet. 1985; 37(1): 1-31.
  28. Snow C.F. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch. Intern. Med. 1999; 159(12): 1289-98.
  29. Klee G. G. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs. vitamin B(12) and folate. Clin. Chem. 2000; 46(8, Pt 2): 1277-83.
  30. Friso S., Choi S.W., Girelli D., Mason J.B., Dolnikowski G.G., Bagley P.J. et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. USA. 2002; 99(8): 5606-11.
  31. McMullin M.F., Young P.B., Bailie K.E., Savage G.A., Lappin T.R., White R. Homocysteine and methylmalonic acid as indicators of folate and vitamin B12 deficiency in pregnancy. Clin. Lab. Haematol. 2001; 23(3): 161-5.
  32. Cotter A.M., Molloy A.M., Scott J.M., Daly S.F Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am. J. Obstet. Gynecol. 2001; 185(4): 781-5.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2014
##common.cookie##